Skip to content

Robust AI Framework for Comprehensive Tuberculosis Drug Resistance Profiling with Rapid Adaptability

Jul 2026 · medRxiv · 0 citations
Medicine

TL;DR

MuseAMR, a multimodal, multi-label deep-learning framework that predicts both individual-drug resistance and clinically actionable composite phenotypes from Mycobacterium tuberculosis genomes, shows robust cross-regional performance and few-shot adaptation to emerging drugs, supporting its potential for regimen-level tuberculosis resistance profiling and surveillance.

View source

Similar papers

Review Open access Sep 2026

Artificial Intelligence in Drug Susceptibility Testing for Multidrug-resistant Tuberculosis: Genomic Prediction, Automated Phenotyping and Clinical Translation

This critical narrative review evaluates how these approaches may improve susceptibility prediction for multidrug- and rifampicin-resistant tuberculosis, where their evidence is strongest, and which methodological and implementation barriers limit clinical adoption.

Bako Helen Yakubu, Ajide Bukola Adeyoola, Olokun Alexander Lanzema · 0 citations
Open access Sep 2026

Harnessing Bioinformatics to Decode Drug Resistance and Guide Vaccine Design in Mycobacterium tuberculosis

This study provides a thorough examination of bioinformatics research, highlighting how the integration of genomic, proteomic and metabolomic data into TB research has revolutionised the way TB is studied, particularly in understanding resistance mechanisms, identifying new therapeutic targets, and expediting the devel...

Ahmed Mohammed Hayawi · 0 citations
Open access Sep 2026

Protein-based resistance in-silico model (PRISM-TB) for rapid prediction of drug-resistant tuberculosis using machine learning

This study highlights the potential of integrating protein-level mutation data with interpretable machine learning models for rapid, in-silico prediction of MDR-TB, offering a cost-effective approach to resistance screening.

Theja K. V., Ram Shankar Barai, U. D. Ranganathan et al. · 0 citations
Open access Oct 2026

MtbAIM: AI/ML-guided endpoint-specific prediction of small-molecule activity across drug-susceptible and drug-resistant Mycobacterium tuberculosis

The emergence of drug resistance in Mycobacterium tuberculosis (M.tb) presents a major challenge to drug discovery, as compounds active against drug-susceptible (DS) isolates may not retain comparable inhibitory activity against drug-resistant (DR) isolates. Here, we developed an AI/ML workflow to independently priorit...

Jasdeep Singh, Kritika Singh · 0 citations
Review Open access Oct 2026

Artificial intelligence approaches to resistome profiling and predictive antimicrobial resistance surveillance

Antimicrobial resistance (AMR) is a complex One Health challenge driven by the interconnected emergence, selection, persistence, and dissemination of resistance across clinical, animal, agricultural, food, and environmental microbiomes. Resistome profiling through whole-genome and metagenomic sequencing has transformed...

Christian Joseph N. Ong, R. Nazari, J. T. P. Cruz · 0 citations
Open access Sep 2026

Learning and forecasting shared evolutionary pathways to multi-drug resistance across global pathogens

This work identifies global patterns in MDR evolutionary pathways, remarkably shared across multiple ESKAPEE species, and infer these evolutionary pathways across ESKAPEE pathogens using evolutionary accumulation modelling (EvAM), an emerging class of machine learning methods with roots in cancer progression.

Olav N. L. Aga, Sabrina J. Moyo, Jakob Fernø et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.